BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8033770)

  • 1. Cardiovascular risk factor profiles in mild to moderate hypertensives seen at Kenyatta National Hospital.
    Yonga GO; Ogola EN; Juma FD
    East Afr Med J; 1993 Nov; 70(11):693-5. PubMed ID: 8033770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of electrocardiographic left ventricular hypertrophy to blood pressure, body mass index, serum lipids and blood sugar levels in adult Nigerians.
    Opadijo OG; Omotoso AB; Akande AA
    Afr J Med Med Sci; 2003 Dec; 32(4):395-9. PubMed ID: 15259925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study.
    de Simone G; Olsen MH; Wachtell K; Hille DA; Dahlöf B; Ibsen H; Kjeldsen SE; Lyle PA; Devereux RB
    J Hum Hypertens; 2007 Aug; 21(8):625-32. PubMed ID: 17476291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension and associated cardiovascular risk factors in Kelantan.
    Mafauzy M; Mokhtar N; Wan Mohamad WB
    Med J Malaysia; 2003 Oct; 58(4):556-64. PubMed ID: 15190632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk stratification according to the 2003 ESH-ESC guidelines in uncomplicated patients with essential hypertension: comparison with the 1999 WHO/ISH guidelines criteria.
    Cuspidi C; Meani S; Salerno M; Severgnini B; Fusi V; Valerio C; Catini E; Magrini F; Zanchetti A
    Blood Press; 2004; 13(3):144-51. PubMed ID: 15223722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fasting glucose and cardiovascular risk factors in an urban population.
    Gupta R; Sarna M; Thanvi J; Sharma V; Gupta VP
    J Assoc Physicians India; 2007 Oct; 55():705-9. PubMed ID: 18173023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose metabolism in patients with essential hypertension.
    García-Puig J; Ruilope LM; Luque M; Fernández J; Ortega R; Dal-Ré R;
    Am J Med; 2006 Apr; 119(4):318-26. PubMed ID: 16564774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of coronary heart disease risk factors in Nigerians with systemic hypertension.
    Opadijo OG; Akande AA; Jimoh AK
    Afr J Med Med Sci; 2004 Jun; 33(2):121-5. PubMed ID: 15565928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Waist circumference predicts cardiometabolic and global Framingham risk among women screened during National Woman's Heart Day.
    Mosca L; Edelman D; Mochari H; Christian AH; Paultre F; Pollin I
    J Womens Health (Larchmt); 2006; 15(1):24-34. PubMed ID: 16417415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Arrhythmia risk and noninvasive markers in hypertensive left ventricular hypertrophy].
    Akdeniz B; Güneri S; Badak O; Aslan O; Tamci B
    Anadolu Kardiyol Derg; 2002 Jun; 2(2):121-9; AXVII. PubMed ID: 12134537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for erectile dysfunction and associated cardiovascular risk factors in Israeli men.
    Heruti RJ; Steinvil A; Shochat T; Saar N; Mashav N; Arbel Y; Justo D
    Isr Med Assoc J; 2008 Oct; 10(10):686-90. PubMed ID: 19009946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic effects of propranolol and hydroflumethiazide treatment in Kenyans with mild to moderate essential hypertension.
    Yonga GO; Ogola EN; Orinda DA
    East Afr Med J; 1993 Nov; 70(11):696-700. PubMed ID: 8033771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The voltage of R wave in lead aVL improves risk stratification in hypertensive patients without ECG left ventricular hypertrophy.
    Verdecchia P; Angeli F; Cavallini C; Mazzotta G; Repaci S; Pede S; Borgioni C; Gentile G; Reboldi G
    J Hypertens; 2009 Aug; 27(8):1697-704. PubMed ID: 19424088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure at health screening as a predictor of coronary heart disease in Kyoto.
    Sasaki S; Nakamura K; Uchida A; Fujita H; Itoh H; Nakata T; Takeda K; Nakagawa M
    J Cardiovasc Risk; 1996 Feb; 3(1):77-82. PubMed ID: 8783034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines.
    Mancini T; Kola B; Mantero F; Boscaro M; Arnaldi G
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):768-77. PubMed ID: 15579193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive correlation of CRP and fibrinogen levels as cardiovascular risk factors in early stage of continuous ambulatory peritoneal dialysis patients.
    Tekin IO; Pocan B; Borazan A; Ucar E; Kuvandik G; Ilikhan S; Demircan N; Ozer C; Kadayifci S
    Ren Fail; 2008; 30(2):219-25. PubMed ID: 18300125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of global cardiovascular risk assessment on the management of hypertension in southwestern France].
    Vernier I; Amar J; Ruidavets JB; Ferrieres J; Chamontin B
    Arch Mal Coeur Vaiss; 1998 Aug; 91(8):1055-7. PubMed ID: 9749164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypertension management in general practice in Iceland].
    Jensdóttir JO; Sigurethsson EL; Thornorgeirsson G
    Laeknabladid; 2006 May; 92(5):375-80. PubMed ID: 16741320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between aortic stiffness and cardiovascular risk factors in a population of normotensives, white-coat normotensives, white-coat hypertensives, sustained hypertensives and diabetic patients.
    Silva JA; Barbosa L; Bertoquini S; Maldonado J; Polónia J
    Rev Port Cardiol; 2004 Dec; 23(12):1533-47. PubMed ID: 15732656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [QT dispersion intervals in hypertensives with left ventricular hypertrophy].
    Ghanem Wisam MA; Murín J; Jaber J; Radman A; Bulas J; Kozliková K
    Vnitr Lek; 2001 Jan; 47(1):20-4. PubMed ID: 15635864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.